(Q33704177)

28 July 2017

1 reference

title

Functional hyperdopaminergia in dopamine transporter knock-out mice (English)

1 reference

28 July 2017

0 references

1

1 reference

28 July 2017

3

Caron MG

1 reference

28 July 2017

Jones SR

2

1 reference

PubMed ID

10435196

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

28 July 2017

Biological Psychiatry

1 reference

28 July 2017

46

1 reference

28 July 2017

303-311

1 reference

28 July 2017

3

1 reference

Neurotransmitter transporters: recent progress

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

No evidence for linkage or association between the dopamine transporter gene and schizophrenia in a French population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Perspectives on the discovery of central monoaminergic neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis1Published on the World Wide Web on 27 January 1998.1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Evoked extracellular dopamine in vivo in the medial prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Molecular characterization of the dopamine transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Development of dopamine neurotransmission and uptake inhibition in the caudate nucleus as measured by fast-cyclic voltammetry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Profound neuronal plasticity in response to inactivation of the dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Loss of autoreceptor functions in mice lacking the dopamine transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Quantitative microdialysis of neurotransmitters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Dopamine receptor supersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Molecular and cellular basis of addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Developmentally regulated glycosylation of dopamine transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Cocaine in utero enhances the behavioral response to cocaine in adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Genotypic association between dopamine transporter gene polymorphisms and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Cocaine receptors on dopamine transporters are related to self-administration of cocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

The neural basis of drug craving: an incentive-sensitization theory of addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Neurobiological issues in Tourette syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

Psychostimulant drugs increase glucose utilization in the shell of the rat nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900122-5

10.1016/S0006-3223(99)00122-5

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10435196